Plante Moran Financial Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Plante Moran Financial Advisors’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$5.29K	–	921
2022 Q4	$5.29K	Hold	500	–	–	﹤0.01%	665
2022 Q3	$2K	Hold	500	–	–	﹤0.01%	805
2022 Q2	$2K	Hold	500	–	–	﹤0.01%	867
2022 Q1	$4K	Hold	500	–	–	﹤0.01%	706
2021 Q4	$3K	Hold	500	–	–	﹤0.01%	903
2021 Q3	$3K	Hold	500	–	–	﹤0.01%	850
2021 Q2	$4K	Hold	500	–	–	﹤0.01%	833
2021 Q1	$5K	Hold	500	–	–	﹤0.01%	794
2020 Q4	$8K	Sell	500 -500	-50%	-$7.49K	﹤0.01%	659
2020 Q3	$13K	Buy	1,000 +500	+100%	+$6.32K	﹤0.01%	571
2020 Q2	$7K	Sell	500 -14,500	-97%	-$183K	﹤0.01%	563
2020 Q1	$138K	Buy	+15,000	New	+$193K	0.06%	153

Other funds holding PRVB

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Plante Moran Financial Advisors's PRVB Position: Q1 2023 in Review

Plante Moran Financial Advisors sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2023, closing a stake of 500 shares — an estimated $5.29K sold.

Plante Moran Financial Advisors first reported a position in PRVB in Q1 2020 and held it in 12 quarters. The position peaked at $138K in Q1 2020. 182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

Plante Moran Financial Advisors reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Plante Moran Financial Advisors sold 500 Provention Bio, Inc. Common Stock shares in Q1 2023, an estimated $5.29K.
Plante Moran Financial Advisors first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 12 quarters.
Plante Moran Financial Advisors's Provention Bio, Inc. Common Stock position peaked at $138K in Q1 2020.
182 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q1 2023, filed 8 May 2023.